Potokar, M., Korva, M., Jorgacevski, J., Avsic-Zupanc, T
Witard, Daniel Peckham, Theocharis Ispoglou, Ajay Pratap Singh PLOS ONE.2022
The next generation of weight loss
This inhibition preserves cellular NAD+ levels by reducing their consumption, simultaneously increasing GLUT4 transporter expression and activating sirtuin 1, known as the "longevity gene." The compound exhibits high membrane permeability and selectivity without affecting related methyltransferases or NAD+ salvage pathway enzymes, creating targeted metabolic effects while maintaining cellular safety
Titration pacing matters In the Phase 2 NEJM trial, GI side effect rates nearly doubled when participants jumped to 8 mg instead of climbing gradually from 1-2 mg
Patel: Cancers, autoimmune conditions, metabolic disorders, heart disease, you can just name it, all of them is linked to oxidative stress